187 related articles for article (PubMed ID: 10376713)
1. Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy.
Grundmann-Kollmann M; Kaskel P; Leiter U; Krähn G; Behrens S; Peter RU; Kerscher M
Arch Dermatol; 1999 Jun; 135(6):724-5. PubMed ID: 10376713
[No Abstract] [Full Text] [Related]
2. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
[TBL] [Abstract][Full Text] [Related]
3. Bullous pemphigoid treated with mycophenolate mofetil.
Böhm M; Beissert S; Schwarz T; Metze D; Luger T
Lancet; 1997 Feb; 349(9051):541. PubMed ID: 9048797
[No Abstract] [Full Text] [Related]
4. Successful therapy for bullous pemphigoid with mycophenolate mofetil.
Nousari HC; Griffin WA; Anhalt GJ
J Am Acad Dermatol; 1998 Sep; 39(3):497-8. PubMed ID: 9738791
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
Nousari HC; Sragovich A; Kimyai-Asadi A; Orlinsky D; Anhalt GJ
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil monotherapy for pemphigus vulgaris.
Bredlich RO; Grundmann-Kollmann M; Behrens S; Kerscher M; Peter RU
Br J Dermatol; 1999 Nov; 141(5):934. PubMed ID: 10583186
[No Abstract] [Full Text] [Related]
8. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid.
Bystryn JC
Arch Dermatol; 2008 Jul; 144(7):946. PubMed ID: 18645153
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
Grundmann-Kollmann M; Korting HC; Behrens S; Kaskel P; Leiter U; Krähn G; Kerscher M; Peter RU
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
[TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil.
Sakanoue M; Kawai K; Kanekura T
J Dermatol; 2012 Oct; 39(10):884-5. PubMed ID: 22168231
[No Abstract] [Full Text] [Related]
12. A case of refractory antilaminin γ1 pemphigoid successfully treated with dexamethasone and mycophenolate mofetil.
Zhiliang L; Xiaodong Z; Peiying J; Suying F; Baoxi W
Int J Dermatol; 2015; 54(5):e194-6. PubMed ID: 25773159
[No Abstract] [Full Text] [Related]
13. Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.
Ratnam KV
Singapore Med J; 2001 Oct; 42(10):482-4. PubMed ID: 11874153
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
Megahed M; Schmiedeberg S; Becker J; Ruzicka T
J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
[TBL] [Abstract][Full Text] [Related]
15. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
16. Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil.
Alloo A; Strazzula L; Rothschild B; Hawryluk E; Levine D; Hoang MP; Koga H; Hashimoto T; Kroshinsky D
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1401-3. PubMed ID: 24397852
[No Abstract] [Full Text] [Related]
17. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Doukaki S; Platamone A; Alaimo R; Bongiorno MR
J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris.
Baskan EB; Yilmaz M; Tunali S; Saricaoglu H
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1432-4. PubMed ID: 19470052
[TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy.
Fox JC; Kenkare S; Petronic-Rosic V; Soltani K; Sethi A
Pediatr Dermatol; 2010; 27(5):537-9. PubMed ID: 20807355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
